leisure time -WSS

leisure time

author：focus 2025-09-28 21:11:30 - browse：5

Stain of a biopsy specimen of a rhabdoid tumor -- health coverage from STAT — Stain of a biopsy specimen of a rhabdoid tumor. Wikimedia Commons

Most targeted cancer drugs work like tranquilizer darts, snaring an overzealous gene that has spurred the cell into murderously rapid growth.

But many tumors don’t have a hyperactive gene. Like the mayhem in “Cat in the Hat,” they are enabled by parental absence. They grow because the genes that are meant to provide discipline, guiding the activity of other genes or self-destructing a cell whose DNA is too damaged, are broken or missing.

These tumors have bedeviled researchers for decades. Restoring or fixing a protein is far harder than breaking it. And that’s bad news for humanity: Cancer is far more likely to be caused by such “tumor-suppressor” genes than by one gene run amok.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： In utero gene editing: an explainer

WSS

NIH study of ME/CFS points to clear biological hallmarks

New documents shed light on MD Anderson Cancer Institute feud

MD Anderson's Padmanee Sharma responds to research credit suit

He's a Nobel laureate. Critics say he was misleading on Covid

6 phony surgeries that take placebo to the extreme

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

Wikipedia

leisure time

focus

Tori Bowie and the unacceptable rates of Black maternal death

AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

Jerome Adams on the need for new antivirals for Covid

AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Ukraine seeks to reclaim its role as a hub for clinical trials

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

Guidelines to prevent youth baseball injuries need more muscle

Obamacare plans could cover weight loss drugs

knowledge

Abridge raises $150m as clinical notes automation market heats up

In 'major milestone,' FDA approves first cell therapy for solid tumors

New documents shed light on MD Anderson Cancer Institute feud

Researchers tackle phage therapy hurdles for wider adoption

Readout LOUD podcast: Pharma in Washington, Alnylam, and Gilead

Obesity drugs seen as possible treatment for liver disease MASH

focus

focus

knowledge

leisure time